Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation.


Journal

Journal of hepatology
ISSN: 1600-0641
Titre abrégé: J Hepatol
Pays: Netherlands
ID NLM: 8503886

Informations de publication

Date de publication:
04 2019
Historique:
received: 23 08 2018
revised: 14 11 2018
accepted: 08 12 2018
pubmed: 26 12 2018
medline: 22 9 2020
entrez: 25 12 2018
Statut: ppublish

Résumé

Although there is increasing interest in its use, definitive evidence demonstrating a benefit for postmortem normothermic regional perfusion (NRP) in controlled donation after circulatory death (cDCD) liver transplantation is lacking. The aim of this study was to compare results of cDCD liver transplants performed with postmortem NRP vs. super-rapid recovery (SRR), the current standard for cDCD. This was an observational cohort study including all cDCD liver transplants performed in Spain between June 2012 and December 2016, with follow-up ending in December 2017. Each donor hospital determined whether organ recovery was performed using NRP or SRR. The propensity scores technique based on the inverse probability of treatment weighting (IPTW) was used to balance covariates across study groups; logistic and Cox regression models were used for binary and time-to-event outcomes. During the study period, there were 95 cDCD liver transplants performed with postmortem NRP and 117 with SRR. The median donor age was 56 years (interquartile range 45-65 years). After IPTW analysis, baseline covariates were balanced, with all absolute standardised differences <0.15. IPTW-adjusted risks were significantly improved among NRP livers for overall biliary complications (odds ratio 0.14; 95% CI 0.06-0.35, p <0.001), ischaemic type biliary lesions (odds ratio 0.11; 95% CI 0.02-0.57; p = 0.008), and graft loss (hazard ratio 0.39; 95% CI 0.20-0.78; p = 0.008). The use of postmortem NRP in cDCD liver transplantation appears to reduce postoperative biliary complications, ischaemic type biliary lesions and graft loss, and allows for the transplantation of livers even from cDCD donors of advanced age. This is a propensity-matched nationwide observational cohort study performed using livers recovered from donors undergoing cardiac arrest provoked by the intentional withdrawal of life support (controlled donation after circulatory death, cDCD). Approximately half of the livers were recovered after a period of postmortem in situ normothermic regional perfusion, which restored warm oxygenated blood to the abdominal organs, whereas the remainder were recovered after rapid preservation with a cold solution. The study results suggest that the use of postmortem normothermic regional perfusion helps reduce rates of post-transplant biliary complications and graft loss and allows for the successful transplantation of livers from older cDCD donors.

Sections du résumé

BACKGROUND & AIMS
Although there is increasing interest in its use, definitive evidence demonstrating a benefit for postmortem normothermic regional perfusion (NRP) in controlled donation after circulatory death (cDCD) liver transplantation is lacking. The aim of this study was to compare results of cDCD liver transplants performed with postmortem NRP vs. super-rapid recovery (SRR), the current standard for cDCD.
METHODS
This was an observational cohort study including all cDCD liver transplants performed in Spain between June 2012 and December 2016, with follow-up ending in December 2017. Each donor hospital determined whether organ recovery was performed using NRP or SRR. The propensity scores technique based on the inverse probability of treatment weighting (IPTW) was used to balance covariates across study groups; logistic and Cox regression models were used for binary and time-to-event outcomes.
RESULTS
During the study period, there were 95 cDCD liver transplants performed with postmortem NRP and 117 with SRR. The median donor age was 56 years (interquartile range 45-65 years). After IPTW analysis, baseline covariates were balanced, with all absolute standardised differences <0.15. IPTW-adjusted risks were significantly improved among NRP livers for overall biliary complications (odds ratio 0.14; 95% CI 0.06-0.35, p <0.001), ischaemic type biliary lesions (odds ratio 0.11; 95% CI 0.02-0.57; p = 0.008), and graft loss (hazard ratio 0.39; 95% CI 0.20-0.78; p = 0.008).
CONCLUSIONS
The use of postmortem NRP in cDCD liver transplantation appears to reduce postoperative biliary complications, ischaemic type biliary lesions and graft loss, and allows for the transplantation of livers even from cDCD donors of advanced age.
LAY SUMMARY
This is a propensity-matched nationwide observational cohort study performed using livers recovered from donors undergoing cardiac arrest provoked by the intentional withdrawal of life support (controlled donation after circulatory death, cDCD). Approximately half of the livers were recovered after a period of postmortem in situ normothermic regional perfusion, which restored warm oxygenated blood to the abdominal organs, whereas the remainder were recovered after rapid preservation with a cold solution. The study results suggest that the use of postmortem normothermic regional perfusion helps reduce rates of post-transplant biliary complications and graft loss and allows for the successful transplantation of livers from older cDCD donors.

Identifiants

pubmed: 30582980
pii: S0168-8278(18)32632-1
doi: 10.1016/j.jhep.2018.12.013
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

658-665

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Auteurs

Amelia J Hessheimer (AJ)

Department of General & Digestive Surgery, Institut de Malalties Digestives i Metabòliques (IMDiM), Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain.

Elisabeth Coll (E)

Organización Nacional de Trasplantes, Madrid, Spain.

Ferrán Torres (F)

Medical Statistics Core Facility, IDIBAPS, Hospital Clínic Barcelona & Biostatistics Unit, Faculty of Medicine, Universidad Autónoma de Barcelona, Barcelona, Spain.

Patricia Ruíz (P)

Hospital Universitario Cruces, Bilbao, Spain.

Mikel Gastaca (M)

Hospital Universitario Cruces, Bilbao, Spain.

José Ignacio Rivas (JI)

Complejo Hospitalario Universitario La Coruña, La Coruña, Spain.

Manuel Gómez (M)

Complejo Hospitalario Universitario La Coruña, La Coruña, Spain.

Belinda Sánchez (B)

Hospital Regional Universitario de Málaga, Málaga, Spain.

Julio Santoyo (J)

Hospital Regional Universitario de Málaga, Málaga, Spain.

Pablo Ramírez (P)

Hospital Clínico Universitario Virgen de la Arrixaca (IMIB), Murcia, Spain.

Pascual Parrilla (P)

Hospital Clínico Universitario Virgen de la Arrixaca (IMIB), Murcia, Spain.

Luis Miguel Marín (LM)

Hospital Universitario Virgen del Rocío, Seville, Spain.

Miguel Ángel Gómez-Bravo (MÁ)

Hospital Universitario Virgen del Rocío, Seville, Spain.

Juan Carlos García-Valdecasas (JC)

Department of General & Digestive Surgery, Institut de Malalties Digestives i Metabòliques (IMDiM), Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain.

Javier López-Monclús (J)

Hospital Universitario Puerta de Hierro, Majadahonda, Spain.

Andrea Boscá (A)

Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Rafael López-Andújar (R)

Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Jiliam Fundora-Suárez (J)

Hospital Universitario Virgen de las Nieves, Granada, Spain.

Jesús Villar (J)

Hospital Universitario Virgen de las Nieves, Granada, Spain.

Álvaro García-Sesma (Á)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Carlos Jiménez (C)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Gonzalo Rodríguez-Laíz (G)

Department of General & Digestive Surgery, ISABIAL, Hospital General Universitario de Alicante, Alicante, Spain.

Laura Lladó (L)

Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Spain.

Juan Carlos Rodríguez (JC)

Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Manuel Barrera (M)

Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.

Ramón Charco (R)

Hospital Universitario Vall d'Hebrón, Barcelona, Spain.

Jose Ángel López-Baena (JÁ)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Javier Briceño (J)

Hospital Universitario Reina Sofía, Córdoba, Spain.

Fernando Pardo (F)

Clínica Universitaria de Navarra, Pamplona, Spain.

Gerardo Blanco (G)

Hospital Universitario Infanta Cristina, Badajoz, Spain.

David Pacheco (D)

Hospital Universitario Río Hortega, Valladolid, Spain.

Beatriz Domínguez-Gil (B)

Organización Nacional de Trasplantes, Madrid, Spain.

Víctor Sánchez Turrión (V)

Hospital Universitario Puerta de Hierro, Majadahonda, Spain.

Constantino Fondevila (C)

Department of General & Digestive Surgery, Institut de Malalties Digestives i Metabòliques (IMDiM), Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain. Electronic address: cfonde@clinic.ub.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH